Enhancing efficiency and safety in upstream biomanufacturing
Biosimilar development process
Biosimilar medicines represent an important advancement in healthcare, offering greater patient access to biological therapies that might otherwise be cost-prohibitive. The biosimilar development process revolves around a comprehensive comparability assessment between the proposed biosimilar and its reference biological product. The primary goal of the development process isn’t to establish the efficacy and safety of the […]
Advancing biologics manufacturing
Optimize biologics manufacturing with Recombinant Insulin—enhancing cell growth, yield, and process consistency for therapeutic production.
Accelerate the scale-up to clinical phase: Optimizing stem cell culture performance and viral vector titers
From lab to patient-infographic
Monoclonal antibodies | Viral vectors for gene therapy | Cell-based vaccinees | Pluripotent stem cells
Enhancing process efficiency with high-quality animal-free ingredients
Case study- Increase the viral vector production in HEK293 cells
Recombinant Insulin is the essential cell culture ingredient to boost cell proliferation and productivity
The Insulin peptide family
Monoclonal antibodies | Viral vectors for gene therapy | Cell-based vaccinees | Pluripotent stem cells
The insulin and IGF-1 receptors
Monoclonal antibodies | Viral vectors for gene therapy | Cell-based vaccinees | Pluripotent stem cells
